vs
Hudson Pacific Properties, Inc.（HPP）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Hudson Pacific Properties, Inc.的季度营收约是REPLIGEN CORP的1.3倍（$256.0M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -109.4%，领先116.1%），Hudson Pacific Properties, Inc.同比增速更快（22.1% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.4%）
哈德逊太平洋地产是一家房地产投资信托企业，持有1580万平方英尺办公楼、150万平方英尺摄影棚，同时拥有300万平方英尺商用物业的未开发权益，资产布局覆盖美国西海岸及温哥华，注册地位于马里兰州，总部设在洛杉矶，是洛杉矶当地规模最大的独立摄影棚运营商。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HPP vs RGEN — 直观对比
营收规模更大
HPP
是对方的1.3倍
$197.9M
营收增速更快
HPP
高出8.5%
13.6%
净利率更高
RGEN
高出116.1%
-109.4%
两年增速更快
RGEN
近两年复合增速
9.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $256.0M | $197.9M |
| 净利润 | $-280.2M | $13.3M |
| 毛利率 | 60.0% | 52.5% |
| 营业利润率 | -109.8% | 9.0% |
| 净利率 | -109.4% | 6.7% |
| 营收同比 | 22.1% | 13.6% |
| 净利润同比 | -61.5% | 143.9% |
| 每股收益（稀释后） | $-11.57 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HPPRGEN
| Q4 25 | $256.0M | $197.9M | ||
| Q3 25 | $186.6M | $188.8M | ||
| Q2 25 | $190.0M | $182.4M | ||
| Q1 25 | $198.5M | $169.2M | ||
| Q4 24 | $209.7M | $174.1M | ||
| Q3 24 | $200.4M | $154.9M | ||
| Q2 24 | $218.0M | $154.1M | ||
| Q1 24 | $214.0M | $151.3M |
净利润HPPRGEN
| Q4 25 | $-280.2M | $13.3M | ||
| Q3 25 | $-144.1M | $14.9M | ||
| Q2 25 | $-87.8M | $14.9M | ||
| Q1 25 | $-80.3M | $5.8M | ||
| Q4 24 | $-173.5M | $-30.3M | ||
| Q3 24 | $-107.0M | $-654.0K | ||
| Q2 24 | $-47.6M | $3.3M | ||
| Q1 24 | $-53.4M | $2.1M |
毛利率HPPRGEN
| Q4 25 | 60.0% | 52.5% | ||
| Q3 25 | 44.3% | 53.2% | ||
| Q2 25 | 43.1% | 50.0% | ||
| Q1 25 | 42.9% | 53.6% | ||
| Q4 24 | 44.7% | 26.1% | ||
| Q3 24 | 42.7% | 50.0% | ||
| Q2 24 | 48.0% | 49.8% | ||
| Q1 24 | 48.6% | 49.5% |
营业利润率HPPRGEN
| Q4 25 | -109.8% | 9.0% | ||
| Q3 25 | -77.2% | 8.9% | ||
| Q2 25 | -46.0% | 7.6% | ||
| Q1 25 | -40.4% | 3.9% | ||
| Q4 24 | -83.2% | -17.7% | ||
| Q3 24 | -52.3% | -5.1% | ||
| Q2 24 | -21.6% | 1.0% | ||
| Q1 24 | -24.9% | 1.3% |
净利率HPPRGEN
| Q4 25 | -109.4% | 6.7% | ||
| Q3 25 | -77.2% | 7.9% | ||
| Q2 25 | -46.2% | 8.2% | ||
| Q1 25 | -40.5% | 3.4% | ||
| Q4 24 | -82.7% | -17.4% | ||
| Q3 24 | -53.4% | -0.4% | ||
| Q2 24 | -21.8% | 2.2% | ||
| Q1 24 | -24.9% | 1.4% |
每股收益（稀释后）HPPRGEN
| Q4 25 | $-11.57 | $0.24 | ||
| Q3 25 | $-0.30 | $0.26 | ||
| Q2 25 | $-0.41 | $0.26 | ||
| Q1 25 | $-0.53 | $0.10 | ||
| Q4 24 | $-1.19 | $-0.55 | ||
| Q3 24 | $-0.69 | $-0.01 | ||
| Q2 24 | $-0.33 | $0.06 | ||
| Q1 24 | $-0.37 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $138.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $3.0B | $2.1B |
| 总资产 | $7.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HPPRGEN
| Q4 25 | $138.4M | $767.6M | ||
| Q3 25 | $190.4M | $748.7M | ||
| Q2 25 | $236.0M | $708.9M | ||
| Q1 25 | $86.5M | $697.2M | ||
| Q4 24 | $63.3M | $757.4M | ||
| Q3 24 | $90.7M | $784.0M | ||
| Q2 24 | $78.5M | $809.1M | ||
| Q1 24 | $114.3M | $780.6M |
总债务HPPRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HPPRGEN
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.4B | $2.1B | ||
| Q1 25 | $2.8B | $2.0B | ||
| Q4 24 | $2.9B | $2.0B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $3.1B | $2.0B | ||
| Q1 24 | $3.2B | $2.0B |
总资产HPPRGEN
| Q4 25 | $7.3B | $2.9B | ||
| Q3 25 | $7.8B | $2.9B | ||
| Q2 25 | $8.1B | $2.9B | ||
| Q1 25 | $8.0B | $2.9B | ||
| Q4 24 | $8.1B | $2.8B | ||
| Q3 24 | $8.3B | $2.8B | ||
| Q2 24 | $8.4B | $2.9B | ||
| Q1 24 | $8.3B | $2.8B |
负债/权益比HPPRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $121.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流HPPRGEN
| Q4 25 | $121.0M | $25.7M | ||
| Q3 25 | $33.2M | $48.1M | ||
| Q2 25 | $-2.0M | $28.6M | ||
| Q1 25 | $30.5M | $15.0M | ||
| Q4 24 | $164.7M | $39.2M | ||
| Q3 24 | $63.7M | $49.3M | ||
| Q2 24 | $35.6M | $42.2M | ||
| Q1 24 | $65.1M | $44.7M |
自由现金流HPPRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率HPPRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度HPPRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率HPPRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HPP
| Core Office | $217.1M | 85% |
| Studio Segment | $21.8M | 9% |
| Ancillary Revenue | $20.2M | 8% |
| Chargebacks | $3.3M | 1% |
RGEN
暂无分部数据
